Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by dro2017on May 06, 2018 2:02pm
111 Views
Post# 27988922

RE:RE:This is why I'm on the fence with medreleaf deal

RE:RE:This is why I'm on the fence with medreleaf deal
Toasted2 wrote: Hey Dro.

I'm actually of the opinion that Aurora should avoid Canadian takeovers until it can show a decent revenue stream. Throwing more debt and dilution on the books at such high multiples makes absolutely no sense. 
If they need to do takeover to get a foothold in another country, that's another story all together which I would support.
Medreleaf is trying to cash out for its shareholders for a big win...to snap them up after having already grabbed Cannimed is an unnecessary gamble IMO and compromises the balance sheet.
Continue with organic growth and focus on building our own greenhouse space rather than pay huge multiples for someone elses..

Importantly...dont let ego of becoming "the largest Cannabis producer in Canada" be the driver of takeover decisions..If capacity is justified at a price..fine...Just don't pay through the nose and bet the farm...

I've been investing in public companies for a long time and seen more than my fair share of fools over leverage themselves and get their heads handed to them..

T2


Couldn't have said it any better. I completely agree with you. Dilution of cannimed hurt investors who bought in higher than 9. I said in a post few days ago that we need to see the big revenue come in from medicinal and recreational so this company can reach $15 again. My predicted target is 15 by end of summer. Vote will pass on June 7. Target price will be $11 by mid to end of May.
Bullboard Posts